LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/510(k) Clearance for Cannulated, Guidewire SI Joint System
Legal & Regulatory and Reimbursement

510(k) Clearance for Cannulated, Guidewire SI Joint System

May 10, 2024 2 min read Premium comments

Advertisement

510(k) Clearance for Cannulated, Guidewire SI Joint System
Patriot-SI Posterior Implant System / Source: Spinal Simplicity, LLC
Secondary#spinalsimplicity#iilonmedical#libertysi#nadiasi#patriotsi

The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to a novel, cannulated, guidewire directed sacroiliac joint (SI) fusion implant to Overland Park, Kansas-based firm, Spinal Simplicity, LLC.

This new SI joint system is brand named: Patriot-SI Posterior Implant System. It is to be used in conjunction with the Liberty-SI lateral transfixing system.

According to the 510(k) summary document, the system is a “minimally invasive sacroiliac joint fusion implant that is intended for implantation on a trajectory in line with the joint space.” It is offered in one size and “may be implanted using the designated surgical instruments through a posterior approach into the SI joint space, fixating on both the sacrum and ilium via external threads.”

The implant system is “intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.” When the system is implanted, it must be used with a transfixing device “implanted across the same sacroiliac joint to create a hybrid SI joint fusion construct for the purpose of stabilizing and fusing the sacroiliac joint.”

Spinal Simplicity CEO Todd Moseley told OTW, “This announcement today marks a second product milestone in the past five months for Spinal Simplicity.”

Moseley continued, “We’ve already seen excellent patient outcomes with the Liberty-SI Lateral System since its introduction in December 2023. The Patriot-SI technology is constructed intentionally as a cannulated implant, designed for repeatable, reproducible techniques, with the implant traveling directly over the guidewire for precision placement in the SI Joint.”

In addition to the 510(k) clearance, Spinal Simplicity also has patent protection for the device. According to the company, the patent teaches a “novel Patriot-SI cannulated and threaded device, which includes an internal lattice structure to promote fusion.” The cannulated design is “the only posterior SI device that allows continuous control while being delivered over a guidewire.”

Spinal Simplicity submitted the device for 510(k) clearance. Spinal Simplicity is a medical device company focused on developing solutions to treat complex spine conditions.

In order to qualify for 510(k) clearance a device must be substantially equivalent to a predicate device. Here, the implant system has the same indications for use as the predicate device. The predicate device is Ilion Medical Inc.’s NADIA SI Fusion System.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy